Denmark· DK-28105997717
Yescarta
A axicabtagene ciloleucel product, registered in Denmark by Kite Pharma EU B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Axicabtagene ciloleucel is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XL03 (axicabtagene ciloleucel), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Axicabtagene ciloleucel · ATC L01XL03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Manufacturer
- Kite Pharma EU B.V.
- Country
- Denmark (DK)
- ATC code
- L01XL03
- ATC class
- Axicabtagene ciloleucel
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105997717
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for axicabtagene ciloleucel.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Axicabtagene ciloleucel · interactions on record
58 records
- 28 severe
- 30 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XL03
Axicabtagene ciloleucel, as other registers publish it.
- PolandYescartaKite Pharma EU B.V.
- NorwayYescartaKite Pharma EU B.V.
- FinlandYescartaKite Pharma EU B.V.
- IcelandYescartaKite Pharma EU B.V.
- SwitzerlandYescartaGilead Sciences Switzerland Sàrl
- United StatesYESCARTAKite Pharma, Inc.
- United StatesYESCARTAKite Pharma, Inc.
- CzechiaYESCARTAKite Pharma EU B.V., Hoofddorp
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea71eb2f-3028-4671-8edd-2ce47b9fc26d GET /v1/drugs/ea71eb2f-3028-4671-8edd-2ce47b9fc26d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "infusionsvæske, dispersion",
"source": "dkma",
"strength": "16079",
"auth_role": "MOD",
"dk_drugid": "28105997717",
"substance": null,
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43335"
}See everything about axicabtagene ciloleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.